Hydrochloric Acid

Hydrochloric Acid

SCHEMBL316939

OC[C@H]1O[C@@H](Oc2cc3c(O)cc(O)cc3[o+]c2-c2ccc(O)cc2)[C@H](O)[C@@H](O)[C@@H]1O.[Cl-]

nearest known ligand 0.83

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHEBDKRB2CHRM1CHRM2CHRM3CHRNA1CHRNB1CHRNDCHRNECHRNGGUCY1A1GUCY1A2GUCY1B1GUCY1B2NAMPTPTAFRSLC10A2SLC6A2SLC6A3TACR1dacAdacBdacCftsImrcAmrcBmrdA

The experimentally established mechanism targets of Hydrochloric Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ACHE known ✓ P22303 1/20 0.49
CD38 P28907 2/20 0.83
DPP4 P27487 1/20 0.83
F2 P00734 1/20 0.74
SLC28A3 Q9HAS3 3/20 0.53
TYR P14679 2/20 0.51
GLO1 Q04760 2/20 0.50
OR51E2 Q9H255 2/20 0.50
SMN1; SMN2 Q16637 2/20 0.50
ALDH1A1 P00352 1/20 0.50
P4HB P07237 2/20 0.49
CA12 O43570 1/20 0.49
CA2 P00918 1/20 0.49
AKR1B1 P15121 1/20 0.49
CA4 P22748 1/20 0.49
CA7 P43166 1/20 0.49
HPGD P15428 2/20 0.49
HSD17B10 Q99714 2/20 0.49
SLC5A1 P13866 2/20 0.49
KDM4E B2RXH2 1/20 0.49

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Hydrochloric Acid SCHEMBL29991538 1.00 CD38 (0.83) CD38DPP4F2SLC28A3TYR
Hydrochloric Acid SCHEMBL3437710 0.99 CD38 (0.82) CD38DPP4F2SLC28A3TYR
SCHEMBL347415 0.99 CD38 (0.85) CD38DPP4F2SLC28A3TYR
SCHEMBL29816518 0.99 CD38 (0.85) CD38DPP4F2SLC28A3TYR
SCHEMBL29380925 0.99 CD38 (0.85) CD38DPP4F2SLC28A3TYR
SCHEMBL316940 0.99 CD38 (0.85) CD38DPP4F2SLC28A3TYR
Water SCHEMBL30402658 0.98 CD38 (0.83) CD38DPP4F2SLC28A3TYR
Hydrochloric Acid SCHEMBL350109 0.93 F2 (0.81) CD38DPP4F2SLC28A3TYR
Kuromanin SCHEMBL316825 0.92 DPP4 (0.98) CD38DPP4F2SLC28A3GLO1
Kuromanin SCHEMBL440823 0.92 DPP4 (0.98) CD38DPP4F2SLC28A3GLO1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 241 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20260027014-A1 DEVICES AND METHODS RELATED TO COLORIMETRIC DETECTION FOR DENTAL USES CAVISENSE INC (US) 2026-01-29 US claimed
EP-4558090-A1 DEVICES AND METHODS RELATED TO COLORIMETRIC DETECTION FOR DENTAL USES CaviSense Inc. (US) 2025-05-28 EP claimed
WO-2024020581-A1 DEVICES AND METHODS RELATED TO COLORIMETRIC DETECTION FOR DENTAL USES CAVISENSE INC. (US) 2024-01-25 WO claimed
WO-2023219526-A1 MULTITARGET ANTIVIRAL DIETARY SUPPLEMENT PROKIN MILAN (RS) 2023-11-16 WO claimed
US-20230355769-A1 COMPOSITIONS, CONTAINERS, AND METHODS RELATED TO FLAVYLIUM EXCIPIENTS Natural Extraction Systems, LLC (US) 2023-11-09 US claimed
US-20230338331-A1 COMPOSITIONS, CONTAINERS, AND METHODS RELATED TO FLAVYLIUM EXCIPIENTS Natural Extraction Systems, LLC (US) 2023-10-26 US claimed
US-20220279829-A1 Use of Anthocyanin-Anionic Polysaccharide Complex for Preventing or Treating Influenza Virus A Infection JBKLAB CO., LTD. (KR) 2022-09-08 US claimed
US-20220249675-A1 Composition for Preventing, Ameliorating, or Treating Gastritis or peptic Ulcer Comprising Anthocyanin-Negatively Charged Polysaccharide Complex as Active Ingredient JBKLAB CO., LTD. (KR) 2022-08-11 US claimed
EP-3978025-A1 COMPOSITION FOR PREVENTING, AMELIORATING, OR TREATING GASTRITIS OR PEPTIC ULCER COMPRISING ANTHOCYANIN-NEGATIVELY CHARGED POLYSACCHARIDE COMPLEX AS ACTIVE INGREDIENT JBKLAB Co., Ltd. (KR) 2022-04-06 EP claimed
EP-3978026-A1 USE OF ANTHOCYANIN-ANIONIC POLYSACCHARIDE COMPLEX FOR PREVENTING OR TREATING INFLUENZA VIRUS A INFECTION JBKLAB Co., Ltd. (KR) 2022-04-06 EP claimed
CN-1988912-B Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia UNIV MICHIGAN 2013-01-30 CN claimed
US-20120201865-A1 HOT-MELT EXTRUDED COMPOSITIONS CONTAINING PLANT-DERIVED PHENOLIC MATERIALS AND PROCESSES FOR THE PREPARATION THEREOF BOARD OF GOVERNORS FOR HIGHER EDUCATION, STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS (US) 2012-08-09 US claimed
EP-2470157-A1 HOT-MELT EXTRUDED COMPOSITIONS CONTAINING PLANT-DERIVED PHENOLIC MATERIALS AND PROCESSES FOR THE PREPARATION THEREOF The Board of Governors for Higher Education, State of Rhode Island and Providence Plantations (US) 2012-07-04 EP claimed
WO-2011028495-A1 HOT-MELT EXTRUDED COMPOSITIONS CONTAINING PLANT-DERIVED PHENOLIC MATERIALS AND PROCESSES FOR THE PREPARATION THEREOF THE BOARD OF GOVERNORS FOR HIGHER EDUCATION, STATE OF RHODE ISLAND AND PROVIDENCE PLANTATIONS (US) 2011-03-10 WO claimed
US-7887868-B2 low-salt soy sauce having an antihypertensive effect; contains 3.55% or less by weight of sodium, 0.5% to 3.6% by weight of potassium, 0.05 to 20% by weight of at least one polyphenol KAO CORPORATION (JP) 2011-02-15 US claimed
US-7727524-B2 Low sodium liquid seasoning with anti-hypertensive activity KAO CORPORATION (JP) 2010-06-01 US claimed
CN-1993135-A Secretion of insulin by anthocyanins and anthocyanidins UNIV MICHIGAN STATE (US) 2007-07-04 CN claimed
CN-1988912-A Methods and compositions for the treatment of obesity, insulin related diseases and hypercholesterolemia UNIV MICHIGAN STATE (US) 2007-06-27 CN claimed
EP-0496349-B1 Coating solution for preventing adhesion of polymer scale and method for its use SHINETSU CHEMICAL CO (JP) 1996-04-10 EP claimed
EP-0496349-A1 Coating solution for preventing adhesion of polymer scale and method for its use SHIN-ETSU CHEMICAL CO., LTD. (JP) 1992-07-29 EP claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20230355769-A1 COMPOSITIONS, CONTAINERS, AND METHODS RELATED TO FLAVYLIUM EXCIPIENTS CNR2, CNR1, UGT8 ACHE 3117/4885CD38 2308/4885DPP4 4789/4885
US-20230338331-A1 COMPOSITIONS, CONTAINERS, AND METHODS RELATED TO FLAVYLIUM EXCIPIENTS CNR2, CNR1, UGT8 ACHE 3117/4885CD38 2308/4885DPP4 4789/4885
US-20260027014-A1 DEVICES AND METHODS RELATED TO COLORIMETRIC DETECTION FOR DENTAL USES CIB1, TAS2R39, CASR ACHE 118/4885CD38 506/4885DPP4 1052/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.